Evaluation of EEG Power Spectrum in Patients With Traumatic Coma
- Conditions
- Brain Injuries, TraumaticComa
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 210
- Registration Number
- NCT06321146
- Locations
- 🇨🇳
Anhui No.2 Provincial People's Hospital, Hefei, Anhui, China
🇨🇳Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Xiangya Hospital, Central South University, Changsha, Hunan, China
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
- Conditions
- Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisIdiopathic Inflammatory MyopathiesSystemic Sclerosis
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT06316076
- Locations
- 🇨🇳
Department of Rheumatology, Ren Ji Hospital South Campus, School of Medicine, Shanghai JiaoTong University, Shanghai, China
Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease
- Conditions
- Multiple MyelomaBone Diseases
- Interventions
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 478
- Registration Number
- NCT06314698
CytoREductive ProstAtectomy for Poly-metastatic Hormone SensiTIVE Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Drug: Systemic Chemohormonal TherapyDrug: Systemic Hormonal TherapyProcedure: Cytoreductive ProstatectomyProcedure: Postoperative Adjuvant Radiotherapy
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 192
- Registration Number
- NCT06306612
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
A Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HCL001 Cell Injection (Homologous Allogeneic Hepatocytes) in Patients With Decompensated Cirrhosis
- Conditions
- Decompensated Cirrhosis
- Interventions
- Drug: HCL001 cell (homologous allogeneic hepatocytes) injection
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT06306781
Clinical Study Cohort of Idiopathic Inflammatory Myositis
- Conditions
- Idiopathic Inflammatory Myopathies
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06306547
Dalpiciclib in HR+/HER2- ABC
- First Posted Date
- 2024-03-08
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 103
- Registration Number
- NCT06301438
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
fMRI for BPS: A Descriptive Study of Findings and Symptoms
- Conditions
- Bladder Pain Syndrome
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT06294951
- Locations
- 🇨🇳
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Intervention and Effect of Sleep Pattern on Cardio-cerebrovascular Disease
- Conditions
- Cardiovascular DiseasesNon-Communicable Chronic Diseases
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 12800
- Registration Number
- NCT06294964
- Locations
- 🇨🇳
Cardiology, Ren Ji Hospital, Shanghai, China
Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
- Conditions
- Clear-cell Metastatic Renal Cell CarcinomaImmune Checkpoint InhibitorsCytoreductive Nephrectomy
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06279403